Skip to main content
Edit

Talk to us

Business Inquiries
Aaron Blank
CEO & President
+1 206.200.0103
Fearey Offices
The Tower Building
1809 7th Avenue, Suite 1212
Seattle, WA 98101
+1 206.343.1543
  • This field is for validation purposes and should be left unchanged.

Center for Infectious Disease Research nibbles at malaria vaccine

Want more of this?

Sign up for our newsletter and get cutting-edge communications and marketing insights delivered to your inbox.

Center for Infectious Disease Research (client) recently spoke with The Seattle Times about their milestone in developing a vaccine for malaria. Stefan Kappe and his team created a weakened form of the parasite to use as a basis for the vaccine. While this idea isn’t new, their approach certainly is; instead of syringes, they use living mosquitoes to […]

Center for Infectious Disease Research (client) recently spoke with The Seattle Times about their milestone in developing a vaccine for malaria. Stefan Kappe and his team created a weakened form of the parasite to use as a basis for the vaccine. While this idea isn’t new, their approach certainly is; instead of syringes, they use living mosquitoes to inject the weakened parasites into their volunteers. The next round of human trials will begin later this year and will be a crucial test of the vaccine concept.

For more details, check out The Seattle Times article here.

Leave a Reply

Your email address will not be published. Required fields are marked *